Literature DB >> 30287123

The association between subclinical inflammation and abnormal glucose and lipid metabolisms in normal-weight Korean individuals.

M-H Kim1, H-N Kim2, W-S Choi3.   

Abstract

BACKGROUNDS AND AIMS: We aimed to reveal the association between subclinical inflammation and metabolic risk factors and to determine the difference in the association between normal-weight and obese Korean individuals. METHODS AND
RESULTS: Data collected from the Korean National Health and Nutrition Examination Survey (KNHANES) 2015, conducted from January to December 2015, were analyzed. Overall, 4620 subjects were examined and divided into two subgroups: 2987 and 1633 subjects in the normal-weight and obese groups, respectively. The prevalence of obesity in the study population was 34.5% (n = 1633). After multivariate adjustment, impaired fasting glucose (IFG) (odds ratio [OR] 1.22, 95% confidence interval [CI] 1.05-1.42, P = 0.010), high triglyceride (TG) levels (OR 1.29, 95% CI 1.13-1.47, P < 0.001), and low high-density lipoprotein-cholesterol (HDL-C) levels (OR 1.47, 95% CI 1.31-1.64, P < 0.001) were significantly associated with increased high-sensitivity C-reactive protein (hs-CRP) levels in the normal-weight group but not in the obesity group.
CONCLUSION: Subclinical inflammation was associated with IFG, high TG levels, and low HDL-C levels in normal-weight Korean individuals. Prospective and biochemical research is necessary to clarify the role of subclinical systemic inflammation in individuals with normal body weight and its impact on insulin resistance and abnormal lipid metabolism, which promote the incidence of metabolic syndrome and cardiovascular disease.
Copyright © 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Metabolic risk; Normal weight; Obesity; Subclinical inflammation

Mesh:

Substances:

Year:  2018        PMID: 30287123     DOI: 10.1016/j.numecd.2018.06.016

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  3 in total

1.  Anti-inflammatory and antidiabetic effects of grape-derived stilbene concentrate in the experimental metabolic syndrome.

Authors:  Anatoly Kubyshkin; Alina Shevandova; Vitalina Petrenko; Irina Fomochkina; Leya Sorokina; Alexander Kucherenko; Andrey Gordienko; Natalia Khimich; Evgenia Zyablitskaya; Tatiana Makalish; Leonid Aliev; Natalia Kornienko; Ivan Fomochkin
Journal:  J Diabetes Metab Disord       Date:  2020-09-05

2.  Antidyslipidemic, Antioxidant, and Anti-inflammatory Effects of Jelly Drink Containing Polyphenol-Rich Roselle Calyces Extract and Passion Fruit Juice with Pulp in Adults with Dyslipidemia: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Jurairat Khongrum; Pratoomporn Yingthongchai; Kongsak Boonyapranai; Wachira Wongtanasarasin; Nowwapan Donrung; Wanida Sukketsiri; Aree Prachansuwan; Pennapa Chonpathompikunlert
Journal:  Oxid Med Cell Longev       Date:  2022-09-21       Impact factor: 7.310

3.  Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus.

Authors:  Samar Ebrahim Ghanem; Mohamed Abdel-Samiee; Mohamed Hamdy Torky; Ahmed Gaafar; Somia Mokabel Mohamed; Ghada Mohamed Mohamed Salah Eldin; Samah Mohammed Awad; Karema A Diab; Dalia M ELsabaawy; Sania Ali Yehia; Hany Abdelbary Abdelaziz Elbasyouni; Amr Aly Elshormilisy
Journal:  BMJ Open Diabetes Res Care       Date:  2020-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.